Home > Result Summaries: Compounds > dolutegravir > Result Summary for 112934

Result Summary for 112934

Result Summary

Protocol ID:	112934
Clinical Study ID:	ING112934
Official Title:	A Phase I, open label, randomized, three period, one-way, two cohort, adaptive crossover study to evaluate the effect of darunavir/ritonavir plus etravirine and lopinavir/ritonavir plus etravirine on GSK1349572 pharmacokinetics in healthy adult subjects (ING112934)
Phase:	phase 1
Study Indications or Diseases:	Infection, Human Immunodeficiency Virus
Generic Name:	dolutegravir
Trade/Product Name:	dolutegravir
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Song I, Borland J, Min S, et al. Effects of etravirine alone and with ritonavir-boosted protease inhibitors on the pharmacokinetics of dolutegravir. [Antimicrob Agents Chemother]. 2011;55(7):3517-3521.